Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ilal20 Leukemia & Lymphoma ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/ilal20 Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice Daniela Zackova , Hana Klamova , Petra Belohlavkova , Lukas Stejskal , Tereza Necasova , Lukas Semerad , Barbora Weinbergerova , Dana Srbova , Jaroslava Voglova , Petra Cicatkova , Zuzana Sustkova , Tomas Hornak , Jana Baranova , Jirina Prochazkova & Jiri Mayer To cite this article: Daniela Zackova , Hana Klamova , Petra Belohlavkova , Lukas Stejskal , Tereza Necasova , Lukas Semerad , Barbora Weinbergerova , Dana Srbova , Jaroslava Voglova , Petra Cicatkova , Zuzana Sustkova , Tomas Hornak , Jana Baranova , Jirina Prochazkova & Jiri Mayer (2020): Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice, Leukemia & Lymphoma, DOI: 10.1080/10428194.2020.1827242 To link to this article: https://doi.org/10.1080/10428194.2020.1827242 View supplementary material Published online: 06 Oct 2020. Submit your article to this journal Article views: 2 View related articles View Crossmark data